Anlotinib Alone or in Combination With Temozolomide in the Treatment of Recurrent High-Grade Glioma: A Retrospective Analysis

• Main Authors: Qunying Yang (Author), Chengcheng Guo (Author), Xiaoping Lin (Author), Lili Luo (Author), Zhenqiang He (Author), Fuhua Lin (Author), Ji Zhang (Author), Yinsheng Chen (Author), Xiaobing Jiang (Author), Chao Ke (Author), Yonggao Mou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Anlotinib is a multi-target anti-angiogenic agent. This retrospective study aimed to evaluate the efficacy and safety of anlotinib alone or in combination with temozolomide for the treatment of recurrent high-grade glioma.Materials and Methods: The clinical data of patients with recurren...